Application of antimetabolite agents such as mitomycin\_c has improved trabeculectomy results and better control of intraocular pressure complications such as corneal endothelial cell loss. However, Mitomycin\_c can be applied remain a concern before or after sclera flap dissection. Mitomycin\_c application after sclera flap dissection probably increases corneal endothelial cell loss. This study compares Mitomycin\_c application two methods: before and after sclera flap dissection with regard to success rate and complication. patients on base of Mitomycin\_c application time (1-2-3) minutes will be match randomise in to two groups( before and after sclera flap dissection) corneal. Endothelial cell density, polymorphism, polymegathism and intraocular pressure before and one month, three months, six months after surgery will measured.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
0.02%.1,2,3,minutes match randomized in to two groups(before \&after scleral flap dissection
0.02%.1,2,3,minutes match randomized in to two groups(before \&after scleral flap dissection
Labbafinejad medical center
Tehran, Iran
RECRUITINGcorneal endothelial cell density
specular microscopy
Time frame: six month
corneal endothelial cell polymorphism
specular microscopy
Time frame: 6 months
corneal endothelial cell polymegathism
specular microscopy
Time frame: 6 months
IOP (intra ocular pressure)
applanation tonometry
Time frame: six months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.